Security key
90042W100
CUSIP: 90042W100
Security key
90042W100
Report period
Q4 2023
Institutions
36
Top holders
10
Broader feeds
Reporting periods
Recent filing periods:
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Rank 1 holder
Rank 2 holder
Rank 3 holder
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC |
13F
Company
|
13%
|
$12,211,104
3,099,265 shares
|
— | 30 Sep 2023 |
| FMR LLC |
13F
Company
|
12%
|
$11,151,319
2,830,284 shares
|
— | 30 Sep 2023 |
| PFM Health Sciences, LP |
13F
Company
|
6.6%
|
$6,007,357
1,524,710 shares
|
— | 30 Sep 2023 |
| Point72 Asset Management, L.P. |
13F
Company
|
3.6%
|
$3,283,332
833,333 shares
|
— | 30 Sep 2023 |
| EVENTIDE ASSET MANAGEMENT, LLC |
13F
Company
|
3.1%
|
$2,790,769
708,317 shares
|
— | 30 Sep 2023 |
| CITADEL ADVISORS LLC |
13F
Company
|
3%
|
$2,663,417
687,452 shares
|
— | 30 Sep 2023 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Investor-level positions for this CUSIP, loaded as an interactive table.
| Investor | Option | Weight % | Change % | Reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* Reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that failed the local validity check.
| Investor | Q3 2023 Shares | Q4 2023 Shares | Share Diff | Share Chg % | Q3 2023 value | Q4 2023 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).